Press Releases

Press Releases

Media Contact:
Elizabeth Wolffe, Ph.D.
Wheelhouse Life Science Advisors
wolffe@wheelhouselsa.com

Date Title and Summary Additional Format
January 9, 2020 Nurix Therapeutics and Sanofi Establish Strategic Collaboration to Develop Novel Targeted Protein Degradation Therapies
SAN FRANCISCO, Jan. 09, 2020 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc., a company researching novel therapies that control degradation of disease-causing proteins, today announced a global strategic collaboration with Sanofi to discover, develop and commercialize a pipeline of innovative targeted
January 8, 2020 Nurix Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO, January 8, 2019 –  Nurix Therapeutics, Inc., a company developing targeted protein modulation drugs announced today that CEO Arthur Sands will present at the 38th Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2020 at 8:30 a.m. PST in San Francisco.
Displaying 11 - 12 of 12